|
FY2026
12 months to Jun 30, 2026
|
FY2025
12 months to Jun 30, 2025
|
FY2024
12 months to Jun 30, 2024
|
FY2023
12 months to Jun 30, 2023
|
FY2022
12 months to Jun 30, 2022
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Selling, general and administrative | |||||
| Research and development | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Interest and dividend income | |||||
| Realized loss | |||||
| Other income and expense, net | |||||
| Total other income(expense) | |||||
| Loss from operations before income taxes | |||||
| Income tax benefit /(expense) | |||||
| Net loss | |||||
| Available-for-sale securities: | |||||
| Net unrealized gain | |||||
| Total comprehensive loss | |||||
| Weighted average common shares outstanding: | |||||
| Basic and diluted (in shares) | |||||
| Basic and diluted net loss per common share: | |||||
| Net loss per common share (in dollars per share) | |||||
Loading...